These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 10545217

  • 1. Human cut-like repressor protein binds TGFbeta type II receptor gene promoter.
    Jackson RJ, Antonia SJ, Wright KL, Moon NS, Nepveu A, Muñoz-Antonia T.
    Arch Biochem Biophys; 1999 Nov 15; 371(2):290-300. PubMed ID: 10545217
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1.
    Wilder PJ, Bernadt CT, Kim JH, Rizzino A.
    Mol Reprod Dev; 2002 Nov 15; 63(3):282-90. PubMed ID: 12237943
    [Abstract] [Full Text] [Related]

  • 3. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
    Bernadt CT, Rizzino A.
    Mol Reprod Dev; 2003 Aug 15; 65(4):353-65. PubMed ID: 12840808
    [Abstract] [Full Text] [Related]

  • 4. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H.
    Invest Ophthalmol Vis Sci; 2010 Feb 15; 51(2):679-85. PubMed ID: 19737884
    [Abstract] [Full Text] [Related]

  • 5. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW.
    J Cell Physiol; 2003 Jan 15; 194(1):88-99. PubMed ID: 12447993
    [Abstract] [Full Text] [Related]

  • 6. A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression.
    Muñoz-Antonia T, Li X, Reiss M, Jackson R, Antonia S.
    Cancer Res; 1996 Nov 01; 56(21):4831-5. PubMed ID: 8895728
    [Abstract] [Full Text] [Related]

  • 7. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B, Jang JS, Park K.
    Int J Oncol; 2000 Sep 01; 17(3):473-8. PubMed ID: 10938386
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R, Alsarraj M, Wright KL, Muñoz-Antonia T.
    Oncogene; 2001 Oct 18; 20(47):6899-909. PubMed ID: 11687969
    [Abstract] [Full Text] [Related]

  • 9. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
    De M, Yan W, de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Cancer Res; 1998 May 01; 58(9):1986-92. PubMed ID: 9581843
    [Abstract] [Full Text] [Related]

  • 10. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V.
    Mol Cancer Res; 2006 Nov 01; 4(11):861-72. PubMed ID: 17114344
    [Abstract] [Full Text] [Related]

  • 11. The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A.
    van Gurp MF, Pratap J, Luong M, Javed A, Hoffmann H, Giordano A, Stein JL, Neufeld EJ, Lian JB, Stein GS, van Wijnen AJ.
    Cancer Res; 1999 Dec 01; 59(23):5980-8. PubMed ID: 10606245
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC, Matthews JB, Huntley S, Robinson CM, Fahey M, Parkinson EK, Prime SS.
    J Pathol; 2001 Apr 01; 193(4):458-67. PubMed ID: 11276004
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells.
    Kelly D, Kim SJ, Rizzino A.
    J Biol Chem; 1998 Aug 14; 273(33):21115-24. PubMed ID: 9694866
    [Abstract] [Full Text] [Related]

  • 15. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
    Shimanuki T, Hara T, Furuya T, Imamura T, Miyazono K.
    Oncogene; 2007 May 17; 26(23):3311-20. PubMed ID: 17146441
    [Abstract] [Full Text] [Related]

  • 18. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH, Birchenall-Roberts MC, Yi Y, Lee BI, Lee DK, Bertolette DC, Fu T, Ruscetti F, Kim SJ.
    Cell Growth Differ; 2001 Jan 21; 12(1):9-18. PubMed ID: 11205746
    [Abstract] [Full Text] [Related]

  • 20. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V.
    Mol Cell Biol; 2007 Dec 21; 27(23):8228-42. PubMed ID: 17875924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.